Pregnant Woman at Week 38 of Gestation, Lateral View (Asian Skin)

Description

A pregnant woman is shown in profile at 38 weeks of gestation, the abdominal wall rendered translucent so that the greatly enlarged uterus fills the abdominopelvic cavity from the pelvic floor to the level of the costal margin. The fetus lies in cephalic presentation with the head engaged in the maternal pelvis, the spine directed anteriorly, and the limbs flexed against the trunk in the characteristic full-term attitude. The umbilical cord loops between the fetal abdomen and the uterine wall within the amniotic cavity, while the cervix, vagina and urinary bladder are visible inferiorly and anteriorly. Loops of large intestine are displaced superiorly and posteriorly, and the lower ribs are outlined where the fundus presses against them. The lateral projection is the standard orientation for teaching fetal lie, presentation and engagement at term, the assessments that underpin decisions about mode of delivery. It illustrates why fundal height reaches its maximum near this stage, why the descent of the presenting part relieves subcostal pressure while increasing bladder compression and urinary frequency, and how the vertex relates to the pelvic inlet and ischial spines during station assessment. The same view clarifies mechanical consequences of the term uterus, including displacement of the colon, reduced diaphragmatic excursion, aortocaval compression in the supine position, and the relationship of the cervix to the presenting fetal head before labour. The image suits obstetric and midwifery teaching sets, antenatal class handouts and childbirth preparation material, where a clear profile of the term uterus helps explain lightening, engagement and the onset of labour. It also serves textbook and journal figures on fetal presentation, patient-facing leaflets on late pregnancy symptoms, and app or device content for obstetric ultrasound and monitoring, and it reads as the final entry in a week-by-week gestational series. Anatomical accuracy verified by SciePro's Medical Advisory Board.